NCT05551520 is a NA clinical trial of Normative in Concussion, sponsored by ImPACT Applications, Inc..

Who is sponsoring NCT05551520?

NCT05551520 is sponsored by ImPACT Applications, Inc..

What drugs are being tested in NCT05551520?

Interventions in NCT05551520: Normative, Reliability.

What condition does NCT05551520 study?

NCT05551520 studies Concussion.

Is NCT05551520 still recruiting?

NCT05551520 is currently status unknown. Last updated 5 July 2023.

Last reviewed 2023-07-05 · How we verify

NCT05551520

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ImPACT Version 4-Touchscreen: Normative and Reliability Study

Status unknown NA Last updated 5 July 2023

What this trial tests

NA trial testing Normative in Concussion in 1,437 participants. Status unknown.

Timeline

7 February 2022

Primary endpoint
1 June 2024

1 October 2024

Quick facts

Lead sponsor	ImPACT Applications, Inc.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	1,437
Start date	7 February 2022
Primary completion	1 June 2024
Estimated completion	1 October 2024
Sites	1 location across United States

Drugs / interventions tested

Normative
Reliability

Conditions studied

Concussion — all drugs for Concussion →

Sponsor

ImPACT Applications, Inc.

Who can join

Adults 12 to 80, any sex, with Concussion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research study is designed to establish normative database and reliability of ImPACT for adolescents and adults ages 12 through 80 to expand the use of devices to include touchscreen.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Concussion

Currently open trials in the same condition.

NCT05426967 — rTMS for Military TBI-related Depression · NA · recruiting
NCT03710109 — Evaluation of an EEG Based Concussion System · recruiting
NCT03233646 — Retinal Imaging in Neurodegenerative Disease · recruiting

Other ImPACT Applications, Inc. trials

Trials by the same sponsor.

NCT03180905 — ImPACT Normative Extension · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05551520 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ImPACT Applications, Inc.
Last refreshed: 5 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05551520.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing